1-20 of 158
Authors: Paul M Ridker
Save search
Sort by
Journal Article

Clinical staging to guide management of metabolic disorders and their sequelae: a European Atherosclerosis Society consensus statement

PDF
Stefano Romeo and others
European Heart Journal, ehaf314, https://doi.org/10.1093/eurheartj/ehaf314
Published: 07 May 2025
Journal Article

Low-density lipoprotein cholesterol, C-reactive protein, and lipoprotein(a) universal one-time screening in primary prevention: the EPIC-Norfolk study

PDF
Jordan M Kraaijenhof and others
European Heart Journal, ehaf209, https://doi.org/10.1093/eurheartj/ehaf209
Published: 01 April 2025
Journal Article

Expanding the triglyceride range in clinical trials: therapeutic opportunities Get access

PDF
Ask T Nordestgaard and others
European Heart Journal, ehaf074, https://doi.org/10.1093/eurheartj/ehaf074
Published: 14 February 2025
Journal Article

Blood pressure changes during methotrexate treatment: results from a randomized placebo-controlled trial among patients with cardiovascular risk Get access

PDF
Jing Cui and others
Rheumatology, keae604, https://doi.org/10.1093/rheumatology/keae604
Published: 06 December 2024
Journal Article

Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trial

PDF
C Michael Gibson and others
European Heart Journal, Volume 45, Issue 47, 14 December 2024, Pages 5023–5038, https://doi.org/10.1093/eurheartj/ehae614
Published: 02 September 2024
Journal Article

Universal screening for hsCRP in patients with atherosclerotic disease: a Major therapeutic opportunity

PDF
Giovanna Liuzzo and Paul M Ridker
European Heart Journal, Volume 45, Issue 44, 21 November 2024, Pages 4731–4733, https://doi.org/10.1093/eurheartj/ehae565
Published: 30 August 2024
Journal Article

Prediction of individual lifetime cardiovascular risk and potential treatment benefit: development and recalibration of the LIFE-CVD2 model to four European risk regions

PDF
Steven H J Hageman and others
European Journal of Preventive Cardiology, Volume 31, Issue 14, October 2024, Pages 1690–1699, https://doi.org/10.1093/eurjpc/zwae174
Published: 16 May 2024
Journal Article
EDITOR'S CHOICE

Low-dose colchicine for atherosclerosis: long-term safety

PDF
Stefan Mark Nidorf and others
European Heart Journal, Volume 45, Issue 18, 7 May 2024, Pages 1596–1601, https://doi.org/10.1093/eurheartj/ehae208
Published: 10 April 2024
Journal Article

Plasma Biomarker Profiles for Premature and Nonpremature Coronary Heart Disease in Women

PDF
Sagar B Dugani and others
Clinical Chemistry, Volume 70, Issue 5, May 2024, Pages 768–779, https://doi.org/10.1093/clinchem/hvae007
Published: 13 March 2024
Journal Article

Biological basis and proposed mechanism of action of CSL112 (apolipoprotein A-I [human]) for prevention of major adverse cardiovascular events in patients with myocardial infarction

PDF
Serge Korjian and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 4, June 2023, Pages 387–398, https://doi.org/10.1093/ehjcvp/pvad014
Published: 14 February 2023
Journal Article

Interplay of Atherogenic Particle Number and Particle Size and the Risk of Coronary Heart Disease

PDF
Karol M Pencina and others
Clinical Chemistry, Volume 69, Issue 1, January 2023, Pages 48–55, https://doi.org/10.1093/clinchem/hvac172
Published: 04 November 2022
Journal Article

Inflammation drives residual risk in chronic kidney disease: a CANTOS substudy

PDF
Paul M Ridker and others
European Heart Journal, Volume 43, Issue 46, 7 December 2022, Pages 4832–4844, https://doi.org/10.1093/eurheartj/ehac444
Published: 09 August 2022
Journal Article
EDITOR'S CHOICE

Sugar-Sweetened Beverage Consumption and Plasma Lipoprotein Cholesterol, Apolipoprotein, and Lipoprotein Particle Size Concentrations in US Adults

PDF
Danielle E Haslam and others
The Journal of Nutrition, Volume 152, Issue 11, November 2022, Pages 2534–2545, https://doi.org/10.1093/jn/nxac166
Published: 02 August 2022
Journal Article

Proteomics for the prediction and prevention of atherosclerotic disease

PDF
Paul M. Ridker
European Heart Journal, Volume 43, Issue 16, 21 April 2022, Pages 1578–1581, https://doi.org/10.1093/eurheartj/ehac036
Published: 15 February 2022
Journal Article

From RESCUE to ZEUS: will interleukin-6 inhibition with ziltivekimab prove effective for cardiovascular event reduction?

PDF
Paul M Ridker
Cardiovascular Research, Volume 117, Issue 11, 1 October 2021, Pages e138–e140, https://doi.org/10.1093/cvr/cvab231
Published: 05 August 2021
Journal Article

Targeting cytokine storm in COVID-19: what have we learned?

PDF
Paul M Ridker
European Heart Journal Open, Volume 1, Issue 1, August 2021, oeab005, https://doi.org/10.1093/ehjopen/oeab005
Published: 29 July 2021
Journal Article

The neutrophil–lymphocyte ratio: considerations for clinical application

PDF
Nicholas H Adamstein and Paul M Ridker
European Heart Journal, Volume 42, Issue 22, 7 June 2021, Pages 2216–2217, https://doi.org/10.1093/eurheartj/ehab166
Published: 22 March 2021
Journal Article

The neutrophil–lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials

PDF
Nicholas H Adamstein and others
European Heart Journal, Volume 42, Issue 9, 1 March 2021, Pages 896–903, https://doi.org/10.1093/eurheartj/ehaa1034
Published: 08 January 2021
Journal Article

Lipoproteins in chronic kidney disease: from bench to bedside

PDF
Thimoteus Speer and others
European Heart Journal, Volume 42, Issue 22, 7 June 2021, Pages 2170–2185, https://doi.org/10.1093/eurheartj/ehaa1050
Published: 04 January 2021
Journal Article

Adverse effects related to methotrexate polyglutamate levels: adjudicated results from the cardiovascular inflammation reduction trial

PDF
Chang Xu and others
Rheumatology, Volume 60, Issue 6, June 2021, Pages 2963–2968, https://doi.org/10.1093/rheumatology/keaa650
Published: 27 November 2020